dc.contributor.author | Myrbakk, Ingvild Nordnes | |
dc.contributor.author | Friborg, Oddgeir | |
dc.contributor.author | Høye, Anne | |
dc.contributor.author | Steigen, Terje | |
dc.contributor.author | Bergvik, Svein | |
dc.date.accessioned | 2022-04-04T05:58:46Z | |
dc.date.available | 2022-04-04T05:58:46Z | |
dc.date.issued | 2022-02-05 | |
dc.description.abstract | Background: The Coronary Revascularisation Outcome Questionnaire (CROQ) measures health-related quality of life
and outcome of invasive revascularization procedures such as percutaneous coronary intervention (PCI) or coronary
artery bypass grafting (CABG). The CROQ has not been properly validated in Norwegian patient populations. The aim
of this study was to examine the psychometric properties of the Norwegian CROQ in patients admitted to elective
coronary angiographic assessment and receiving PCI. Moreover, to examine its discriminative ability to detect disease
severity and efects of invasive coronary treatment.<p>
<p>Methods: The patients (N=280, M<sub>age</sub>=66.9, SD<sub>age</sub>=8.91) completed the CROQ, prior to an elective coronary angiography and at one year follow-up. Analyses included internal consistency, foor and ceiling efects, and confrmatory
and exploratory factor analyses of the CROQ. Convergent validity was evaluated by comparing CROQ scores with the
RAND-12 measure. Sensitivity to treatment was examined by comparing pre-post efect size diferences between the
PCI treatment and non-treatment group.<p>
<p>Results: Signifcant stenosis qualifying for a PCI was detected in 121 (35.1%) patients. The model ft of the original
CROQ factor model was inadequate in the PCI group. All but one of the CROQ items demonstrated ceiling efects. The
CROQ failed to discriminate between patients’ disease severity prior to the coronary angiography, or improvement in
those receiving versus not receiving PCI.<p>
<p>Conclusion: The present study of the Norwegian version of the CROQ identifed serious problems with the factor
structure, ceiling efects, and lack of sensitivity for disease severity and efects of invasive treatment. Currently, one
cannot recommend the use of CROQ in clinical practice. | en_US |
dc.identifier.citation | Myrbakk, Friborg, Høye, Steigen, Bergvik. Psychometric evaluation of the Coronary Revascularisation Outcome Questionnaire (CROQ) in Norwegian patients admitted to elective coronary angiography and possible percutaneous coronary intervention. Health and Quality of Life Outcomes. 2022 | |
dc.identifier.cristinID | FRIDAID 2000890 | |
dc.identifier.doi | 10.1186/s12955-022-01927-9 | |
dc.identifier.issn | 1477-7525 | |
dc.identifier.uri | https://hdl.handle.net/10037/24689 | |
dc.language.iso | eng | en_US |
dc.publisher | BMC | en_US |
dc.relation.journal | Health and Quality of Life Outcomes | |
dc.rights.holder | Copyright 2022 The Author(s) | en_US |
dc.title | Psychometric evaluation of the Coronary Revascularisation Outcome Questionnaire (CROQ) in Norwegian patients admitted to elective coronary angiography and possible percutaneous coronary intervention | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |